Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors

Molecular Pharmacology

Volumn 64, Issue 4, 2003, Pages 994-1005

  Ohta, Hideo ^a   Sato, Koichi ^b   Murata, Naoya ^b   Damirin, Alatangaole ^b   Malchinkhuu, Enkhzol ^b   Kon, Junko ^b   Kimura, Takao ^b   Tobo, Masayuki ^b   Yamazaki, Yuji ^a   Watanabe, Tomoko ^a   Yagi, Mikio ^a   Sato, Motoko ^a   Suzuki, Rika ^a   Murooka, Hideko ^a   Sakai, Teruyuki ^a   Nishitoba, Tsuyoshi ^a   Im, Dong Soon ^c   Nochi, Hiromi ^d   Tamoto, Koichi ^d   Tomura, Hideaki ^b   Okajima, Fumikazu ^b   more..

^a KIRIN BREWERY CO LTD   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c Pusan National University   (South Korea)

^d HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 [4 [[1 (2 CHLOROPHENYL)ETHOXY]CARBONYLAMINO] 3 METHYL 5 ISOXAZOLYL]BENZYLSULFANYL]PROPANOIC ACID; DIOCTYLGLYCEROL PYROPHOSPHATE; GLYCEROPHOSPHATE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KI 16425; KI 6425; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDIC ACID RECEPTOR 3; LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST; PROPIONIC ACID DERIVATIVE; RECEPTOR SUBTYPE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MIGRATION; CELL STRAIN HL 60; CHO CELL; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

ANIMALS; CALCIUM; CELL LINE; CHO CELLS; CRICETINAE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HL-60 CELLS; HUMANS; ISOXAZOLES; PROPIONIC ACIDS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID;

EID: 0141570981     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.4.994     Document Type: Article

References (38)

1. An S, Bleu T, Hallmark OG, and Goetzl EJ (1998a) Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem 273:7906-7910.
2. An S, Bleu T, Zheng Y, and Goetzl EJ (1998b) Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol Pharmacol 54:881-888.
3. Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, and Inoue K (1999) Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 274:27776-27785.
4. Contos JJ, Ishii I, and Chun J (2000) Lysophosphatidic acid receptors. Mol Pharmacol 58:1188-1196.
5. Cunnick JM, Dorsey JF, Standley T, Turkson J, Kraker AJ, Fry DW, Jove R, and Wu J (1998) Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J Biol Chem 273:14468-14475.
6. Daub H, Wallasch C, Lankenau A, Herrlich A, and Ullrich A (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO (Eur Mol Biol Organ) J 16:7032-7044.
7. de Ligt RA, Kourounakis AP and IJzerman AP (2000) Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery. Br J Pharmacol 130:1-12.
8. Fischer DJ, Nusser N, Virag T, Yokoyama K, Wang D, Baker DL, Bautista D, Parrill AL, and Tigyi G (2001) Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors. Mol Pharmacol 60:776-784.
9. Hecht JH, Weiner JA, Post SR, and Chun J (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 135:1071-1083.
10. Heise CE, Santos WL, Schreihofer AM, Heasley BH, Mukhin YV, Macdonald TL, and Lynch KR (2001) Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist. Mol Pharmacol 60:1173-1180.
11. Im DS, Heise CE, Harding MA, George SR, O'Dowd BF, Theodorescu D, and Lynch KR (2000) Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol 57:753-759.
12. Kimura T, Watanabe T, Sato K, Kon J, Tomura H, Tamama K, Kuwabara A, Kanda T, Kobayashi I, Ohta H, et al. (2000) Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J 348:71-76.
13. Kon J, Sato K, Watanabe T, Tomura H, Kuwabara A, Kimura T, Tamama K, Ishizuka T, Murata N, Kanda T, et al. (1999) Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J Biol Chem 274:23940-23947.
14. McIntyre TM, Pontsler AV, Silva AR, St Hilaire A, Xu Y, Hinshaw JC, Zimmerman GA, Hama K, Aoki J, Arai H, et al. (2003) Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci USA 100:131-136.
15. Manning TJ Jr, Parker JC, and Sontheimer H (2000) Role of lysophosphatidic acid and rho in glioma cell motility. Cell Motil Cytoskeleton 45:185-199.
16. 2+ influx in human platelets. J Biol Chem 275:19159-19166.
17. Moolenaar WH (1999) Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 253:230-238.
18. Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, Ui M, and Okajima F (2000) Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352: 809-815.
19. Noguchi K, Ishii S, and Shimizu T (2003) Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278:25600-25606.
20. 2+-mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids. J Biol Chem 270:26332-26340.
21. 2+ system in HL-60 leukaemia cells. Biochem J 336:491-500.
22. Pages C, Daviaud D, An S, Krief S, Lafontan M, Valet P, and Saulnier-Blache JS (2001) Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading. J Biol Chem 276:11599-11605.
23. Sano T, Baker D, Virag T, Wada A, Yatomi Y, Kobayashi T, Igarashi Y, and Tigyi G (2002) Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem 277: 21197-21206.
24. Sato K, Tomura H, Igarashi Y, Ui M, and Okajima F (1997) Exogenous sphingosine 1-phosphate induces neurite retraction possibly through a cell surface receptor in PC12 cells. Biochem Biophys Res Commun 240:329-334.
25. Sato K, Tomura H, Igarashi Y, Ui M, and Okajima F (1999) Possible involvement of cell surface receptors in sphingosine 1-phosphate-induced activation of extracellular signal-regulated kinase in C6 glioma cells. Mol Pharmacol 55:126-133.
26. Sato K, Ui M, and Okajima F (2000) Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells. Brain Res Mol Brain Res 85:151-160.
27. 2+ pathway. J Biol Chem 266:12180-12184.
28. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, and Aepfelbacher M (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 96:6931-6936.
29. Tamama K, Kon J, Sato K, Tomura H, Kuwabara A, Kimura T, Kanda T, Ohta H, Ui M, Kobayashi I, et al. (2001) Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. Biochem J 353: 139-146.
30. Tigyi G (2001) Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family. Mol Pharmacol 60:1161-1164.
31. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, and Fukuzawa K (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277:39436-39442.
32. Tomura H, Itoh H, Sho K, Sato K, Nagao M, Ui M, Kondo Y, and Okajima F (1997) βγ subunits of pertussis toxin-sensitive G proteins mediate A1 adenosine receptor agonist-induced activation of phospholipase C in collaboration with thyrotropin. A novel stimulatory mechanism through the cross-talk of two types of receptors. J Biol Chem 272:23130-23137.
33. Ueno A, Nagao R, Watanabe T, Ohta H, and Yagi M (2001), inventors; Kirin Brewery, assignee. Novel isoxazole and thiazole compounds and use thereof as drugs. European patent 1 258 484 A1.
34. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, et al. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158:227-233.
35. Xu Y, Gaudette DC, Boynton JD, Frankel A, Fang XJ, Sharma A, Hurteau J, Casey G, Goodbody A, Mellors A, et al. (1995) Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res 1:1223-1232.
36. Xu Y, Xiao YJ, Baudhuin LM, and Schwartz BM (2001) The role and clinical applications of bioactive lysolipids in ovarian cancer. J Soc Gynecol Investig 8:1-13.
37. Ye X, Ishii I, Kingsbury MA, and Chun J (2002) Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim Biophys Acta 1585:108-113.
38. Zheng Y, Kong Y, and Goetzl EJ (2001) Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane. J Immunol 166:2317-2322.